GLEEVEC Side Effects

7023103-4 | Vision Blurred, Visual Acuity Reduced, Weight Increased
on Sep 21, 2010 Male patient from SPAIN , 55 years of age, was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: vision blurred, visual acuity reduced, weight increased. Gleevec dosage: 400 Mg, Qd.

7021119-5 | Blood Creatinine Increased, Dehydration, Dysarthria, Hypophagia, Nausea, Renal Failure Acute, Speech Disorder, Weight Decreased
Patient was taking Gleevec (View Usage). Patient had the following side effects: blood creatinine increased, dehydration, dysarthria, hypophagia, nausea (What is nausea?), renal failure acute, speech disorder, weight decreased on Sep 23, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 213.8 lb, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: 400 Mg Daily. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), HUMALOG (Unk) (View Humalog Review and Humalog Label ), KLOR CON (Unk) (View Klor-con Review and Klor-con Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), PROPRANOLOL HYDROCHLORIDE (40 Mg, Bid) (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ). Patient was hospitalized.

7021111-0 | Decreased Appetite, Eyelid Oedema, Performance Status Decreased, Platelet Count Decreased
Adverse event was reported on Sep 22, 2010 by a Male patient taking Gleevec (View Usage) (Dosage: 400 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: JAPAN , 78 years of age, weighting 85.98 lb, After Gleevec was administered, patient had the following side effects: decreased appetite, eyelid oedema, performance status decreased, platelet count decreased. During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ). Patient was hospitalized.

7018783-3 | Anuria, Cardiomyopathy, Microangiopathic Haemolytic Anaemia, Pleural Effusion, Renal Failure Acute, Respiratory Failure, Thrombotic Thrombocytopenic Purpura
on Sep 14, 2010 Female patient from UNITED STATES , 22 years of age, was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, cardiomyopathy (What is cardiomyopathy?), microangiopathic haemolytic anaemia, pleural effusion, renal failure acute, respiratory failure, thrombotic thrombocytopenic purpura. Gleevec dosage: 400 Mg, Qd. Patient was hospitalized.


7018390-2 | Intentional Overdose, Suicide Attempt
on Sep 17, 2010 Male patient from TURKEY , weighting 125.7 lb, was treated with Gleevec (View Usage). Patient had the following side effects: intentional overdose, suicide attempt. Gleevec dosage: Unk.

7018365-3 | Muscle Spasms, Transplant
Patient was taking Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: muscle spasms, transplant on Sep 14, 2010 from JAPAN Additional patient health information: Male patient , child 3 years of age, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: 260 Mg/m2, Unk.

7015223-5 | Intervertebral Disc Protrusion, Treatment Noncompliance
Adverse event was reported on Sep 17, 2010 by a Female patient taking Gleevec (View Usage) (Dosage: 600 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , weighting 155.0 lb, Patient experienced the following unwanted or unexpected effects: intervertebral disc protrusion, treatment noncompliance. Patient was hospitalized.

7015217-X | Hepatectomy, Malignant Tumour Excision, Metastases To Liver, Myelofibrosis, Pancytopenia
on Sep 16, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Gleevec (View Usage). Patient had the following side effects: hepatectomy, malignant tumour excision, metastases to liver, myelofibrosis, pancytopenia. Gleevec dosage: .

7013766-1 | Acute Promyelocytic Leukaemia, Dysgeusia, Face Oedema, Mental Disorder, Pancytopenia
on Sep 16, 2010 Male patient from JAPAN , 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: acute promyelocytic leukaemia, dysgeusia, face oedema, mental disorder, pancytopenia. Gleevec dosage: 400 Mg Daily.

7013541-8 | Skin Reaction
Patient was taking Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: skin reaction on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 72 years of age, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: 400 Mg Daily.

7013293-1 | Decreased Appetite, Gastric Cancer, Metastases To Liver, Metastases To Peritoneum, Neoplasm Malignant
Adverse event was reported on Sep 22, 2010 by a Male patient taking Gleevec (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: JAPAN , 46 years of age, Patient had the following side effects: decreased appetite, gastric cancer, metastases to liver, metastases to peritoneum, neoplasm malignant.

7012974-3 | Renal Disorder
on Sep 14, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: renal disorder. Gleevec dosage: Unk.

7012574-5 | Device Occlusion, Hypoxia, Impaired Gastric Emptying, Infection, Nausea, Neoplasm, Neutropenia, Pyrexia
on Sep 20, 2010 Female patient from NETHERLANDS , weighting 24.25 lb, was diagnosed with neurofibromatosis (What is neurofibromatosis?) and was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: device occlusion, hypoxia, impaired gastric emptying, infection (What is infection?), nausea (What is nausea?), neoplasm, neutropenia, pyrexia. Gleevec dosage: 150 Mg. During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), MACROGOL (View Macrogol Review and Macrogol Label ). Patient was hospitalized.

7012416-8 | Cough, Malaise, Pneumonia, Rhinitis
Patient was taking Gleevec (View Usage). Patient had the following side effects: cough, malaise, pneumonia (What is pneumonia?), rhinitis on Sep 21, 2010 from CHILE Additional patient health information: Male patient , 90 years of age, was diagnosed with gastrointestinal stromal tumour and. Gleevec dosage: 400 Mg, Daily. During the same period patient was treated with LOPERAMIDA (View Loperamida Review and Loperamida Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

7009559-1 |
Adverse event was reported on Sep 20, 2010 by a Male patient taking Gleevec (View Usage) (Dosage: 400 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: MALAYSIA , 49 years of age, .

7009483-4 | Bone Marrow Transplant, Diarrhoea, Graft Versus Host Disease, Hypoaesthesia, Leukaemia Recurrent, Muscular Weakness, Paralysis Flaccid, Spinal Cord Disorder
on Sep 10, 2010 Male patient from JAPAN , 45 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow transplant (What is bone marrow transplant?), diarrhoea, graft versus host disease, hypoaesthesia, leukaemia recurrent, muscular weakness, paralysis flaccid, spinal cord disorder. Gleevec dosage: Unk. During the same period patient was treated with DASATINIB (View Dasatinib Review and Dasatinib Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), IRRADIATION/ TOTAL BODY IRRADIATION (View Irradiation/ Total Body Irradiation Review and Irradiation/ Total Body Irradiation Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

7007997-4 | Diarrhoea, Disbacteriosis
on Sep 09, 2010 Male patient from RUSSIAN FEDERATION , 46 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Gleevec (View Usage). Patient had the following side effects: diarrhoea, disbacteriosis. Gleevec dosage: 400 Mg Daily. During the same period patient was treated with NYSTATIN (View Nystatin Review and Nystatin Label ), MEZYM FORTE (View Mezym Forte Review and Mezym Forte Label ), LINEX (View Linex Review and Linex Label ).

7007995-0 | Surgery
Patient was taking Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: surgery (What is surgery?) on Sep 13, 2010 from SOUTH AFRICA Additional patient health information: Male patient , 20 years of age, was diagnosed with gastrointestinal stromal tumour and. Gleevec dosage: Unk. During the same period patient was treated with CREON (View Creon Review and Creon Label ).

7007980-9 | Acute Promyelocytic Leukaemia, Dysgeusia, Face Oedema, Pancytopenia, Psychiatric Symptom
Adverse event was reported on Sep 09, 2010 by a Male patient taking Gleevec (View Usage) (Dosage: 400 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: JAPAN , 55 years of age, Patient experienced the following unwanted or unexpected effects: acute promyelocytic leukaemia, dysgeusia, face oedema, pancytopenia, psychiatric symptom.

7007312-6 | Febrile Neutropenia
on Sep 17, 2010 Female patient from JAPAN , 56 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Gleevec (View Usage). Patient had the following side effects: febrile neutropenia. Gleevec dosage: Unk. Patient was hospitalized.

7007269-8 | Decreased Appetite, Eyelid Oedema, Performance Status Decreased, Platelet Count Decreased
on Sep 09, 2010 Male patient from JAPAN , 78 years of age, weighting 85.98 lb, was diagnosed with chronic myeloid leukaemia and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: decreased appetite, eyelid oedema, performance status decreased, platelet count decreased. Gleevec dosage: 400 Mg Daily. During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ). Patient was hospitalized.

7007264-9 | Bronchial Polyp, Computerised Tomogram Abnormal, Cough, Lung Disorder, Lung Infiltration, Pulmonary Granuloma
Patient was taking Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: bronchial polyp, computerised tomogram abnormal, cough, lung disorder, lung infiltration, pulmonary granuloma on Sep 09, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: .

7005782-0 | Dehydration, Hypoalbuminaemia, Hypomagnesaemia, Malnutrition, Nausea, Renal Failure, Weight Decreased
Adverse event was reported on Sep 08, 2010 by a Male patient taking Gleevec (View Usage) (Dosage: 400 Mg, Qd) was diagnosed with chronic myeloid leukaemia, nausea (What is nausea?) and. Location: UNITED STATES , weighting 135.1 lb, Patient had the following side effects: dehydration, hypoalbuminaemia, hypomagnesaemia, malnutrition, nausea (What is nausea?), renal failure, weight decreased. During the same period patient was treated with SANCUSO PATCH (Unk) (View Sancuso Patch Review and Sancuso Patch Label ), COMPAZINE (Unk) (View Compazine Review and Compazine Label ), KYTRIL (Unk) (View Kytril Review and Kytril Label ), OMEPRAZOLE (20 Mg, Bid) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized and became disabled.

7001553-X | Abdominal Distension, Anaemia, Clostridial Infection, Depressed Level Of Consciousness, Diarrhoea, Dyspnoea, Gastrointestinal Mucosal Exfoliation, Gastrointestinal Oedema, Haematemesis
on Sep 15, 2010 Female patient from JAPAN , weighting 92.59 lb, was diagnosed with gastrointestinal stromal tumour, insomnia, prophylaxis, diarrhoea and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: abdominal distension, anaemia, clostridial infection, depressed level of consciousness, diarrhoea, dyspnoea, gastrointestinal mucosal exfoliation, gastrointestinal oedema, haematemesis. Gleevec dosage: 400 Mg, Daily. During the same period patient was treated with ALLOID (60 Mg, Unk) (View Alloid Review and Alloid Label ), MYSLEE (5 Mg, Unk) (View Myslee Review and Myslee Label ), TAKEPRON (30 Mg, Unk) (View Takepron Review and Takepron Label ), MAALOX (3.6 G, Unk) (View Maalox Review and Maalox Label ), LAC B (3 G, Unk) (View Lac B Review and Lac B Label ), VANCOMYCIN HYDROCHLORIDE (2 G, Unk) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), BIOFERMIN (3 G, Unk) (View Biofermin Review and Biofermin Label ). Patient was hospitalized.

6999820-9 | Adrenal Disorder, Aortic Arteriosclerosis, Aortic Valve Incompetence, Asthenia, Cardiac Failure, Cardiogenic Shock, Catheter Placement, Dilatation Ventricular
on Sep 13, 2010 Male patient from BRAZIL , 73 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal disorder, aortic arteriosclerosis, aortic valve incompetence, asthenia, cardiac failure, cardiogenic shock, catheter placement, dilatation ventricular. Gleevec dosage: 400 Mg, Unk. During the same period patient was treated with SUNITINIB MALATE (Unk) (View Sunitinib Malate Review and Sunitinib Malate Label ). Patient was hospitalized.

6998396-X | Lung Disorder
Patient was taking Gleevec (View Usage). Patient had the following side effects: lung disorder on Sep 08, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: .

6997760-2 | Myelofibrosis, Pancytopenia
Adverse event was reported on Sep 08, 2010 by a Female patient taking Gleevec (View Usage) (Dosage: ) was diagnosed with gastrointestinal stromal tumour and. Location: JAPAN , 62 years of age, After Gleevec was administered, patient had the following side effects: myelofibrosis, pancytopenia.

6993570-0 | Hypoaesthesia, Surgery
on Sep 07, 2010 Male patient from UNITED STATES , weighting 198.4 lb, was diagnosed with dyspepsia and was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, surgery (What is surgery?). Gleevec dosage: 400 Mg, Qd. During the same period patient was treated with CELEBREX (Unk) (View Celebrex Review and Celebrex Label ), CADUET (Unk) (View Caduet Review and Caduet Label ).

6992419-X | Amyotrophy, Blood Creatinine Increased, Cardiac Failure, Dyspnoea, Eyelid Ptosis, Hypothyroidism, Mitral Valve Incompetence, Oedema Peripheral, Pleural Effusion
on Sep 03, 2010 Male patient from FRANCE , 34 years of age, was diagnosed with hypereosinophilic syndrome and was treated with Gleevec (View Usage). Patient had the following side effects: amyotrophy, blood creatinine increased, cardiac failure, dyspnoea, eyelid ptosis, hypothyroidism, mitral valve incompetence, oedema peripheral, pleural effusion. Gleevec dosage: 100 Mg, Qd. Patient was hospitalized.

6988563-3 | Back Pain, Decreased Appetite, Nausea, Neoplasm Malignant, Renal Cancer
Patient was taking Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: back pain (What is back pain?), decreased appetite, nausea (What is nausea?), neoplasm malignant, renal cancer on Mar 31, 2010 from FRANCE Additional patient health information: Male patient , weighting 220.5 lb, was diagnosed with chronic myeloid leukaemia, hypertension, hypercholesterolaemia and. Gleevec dosage: 400 Mg, Qd. During the same period patient was treated with TASIGNA (400 Mg, Bid) (View Tasigna Review and Tasigna Label ), SPRYCEL (100 Mg, Qd) (View Sprycel Review and Sprycel Label ), DILTIAZEM (300 Mg Daily) (View Diltiazem Review and Diltiazem Label ), TAREG (1 Df Daily) (View Tareg Review and Tareg Label ), BISOPROLOL FUMARATE (0.5 Df Daily) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LASIX (40 Mg Qd) (View Lasix Review and Lasix Label ), ENALAPRIL (20 Mg, Qd) (View Enalapril Review and Enalapril Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6987428-0 | Anaemia, Autonomic Neuropathy, Chest Discomfort, Diarrhoea, Dizziness, Dyspnoea, Epistaxis, Eye Haemorrhage, Eyelid Oedema
Adverse event was reported on Sep 03, 2010 by a Female patient taking Gleevec (View Usage) (Dosage: 300 Mg Daily) . Location: JAPAN , weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: anaemia, autonomic neuropathy, chest discomfort, diarrhoea, dizziness (What is dizziness?), dyspnoea, epistaxis, eye haemorrhage, eyelid oedema.

6985190-9 | Abdominal Pain, Asthenia, Colostomy, Depressed Mood, Feeling Abnormal, Frequent Bowel Movements, Gamma-glutamyltransferase Increased, Gastrointestinal Disorder, Increased Appetite
on Sep 03, 2010 Male patient from JAPAN , weighting 163.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with Gleevec (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, colostomy, depressed mood, feeling abnormal, frequent bowel movements, gamma-glutamyltransferase increased, gastrointestinal disorder, increased appetite. Gleevec dosage: 400 Mg, Unk. During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ).

6985186-7 | Abdominal Discomfort, Bladder Catheter Temporary, Contusion, Decreased Appetite, Dyspnoea, Dysuria, Fall, Fluid Retention
on Sep 01, 2010 Female patient from JAPAN , weighting 130.1 lb, was diagnosed with chronic myeloid leukaemia, hypertension, polyuria, prophylaxis and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: abdominal discomfort, bladder catheter temporary, contusion, decreased appetite, dyspnoea, dysuria, fall (What is fall?), fluid retention. Gleevec dosage: 400 Mg Daily. During the same period patient was treated with CONIEL (Unk) (View Coniel Review and Coniel Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), DIOVAN (80 Mg, Unk) (View Diovan Review and Diovan Label ), HYDREA (2000 Mg, Unk) (View Hydrea Review and Hydrea Label ), SELBEX (150 Mg, Unk) (View Selbex Review and Selbex Label ), URSO 250 (200 Mg, Unk) (View Urso 250 Review and Urso 250 Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), AMLODIPINE BESYLATE (10 Mg, Unk) (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6984991-0 | Myelofibrosis
Patient was taking Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: myelofibrosis on Jul 30, 2010 from UNITED STATES Additional patient health information: Female patient , 32 years of age, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: Unk.

6981501-9 | Skin Reaction
Adverse event was reported on Sep 02, 2010 by a Female patient taking Gleevec (View Usage) (Dosage: 400 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: UNITED KINGDOM , 72 years of age, Patient had the following side effects: skin reaction.

6981489-0 | Hypoaesthesia, Leukaemia Recurrent, Muscular Weakness, Paralysis Flaccid
on Sep 01, 2010 Male patient from JAPAN , 45 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: hypoaesthesia, leukaemia recurrent, muscular weakness, paralysis flaccid. Gleevec dosage: Unk.

6981487-7 | Lung Disorder
on Sep 01, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder. Gleevec dosage: .

6980525-5 | Diarrhoea, Parkinson's Disease
Patient was taking Gleevec (View Usage). Patient had the following side effects: diarrhoea, parkinson's disease (What is parkinson's disease?) on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 160.0 lb, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: 400 G, Qd.

6980519-X | Haematotoxicity, Neutropenia
Adverse event was reported on Sep 01, 2010 by a Female patient taking Gleevec (View Usage) (Dosage: 400 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: FRANCE , 53 years of age, After Gleevec was administered, patient had the following side effects: haematotoxicity, neutropenia.

6979380-9 | Abnormal Behaviour, Depression, Mood Altered, Personality Change, Physical Abuse, Verbal Abuse
on Sep 10, 2010 Male patient from UNITED STATES , weighting 230.0 lb, was diagnosed with leukaemia and was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, depression (What is depression?), mood altered, personality change, physical abuse, verbal abuse. Gleevec dosage: One Tablet Daily 2 Tablet Daily. Patient was hospitalized and became disabled.

6979145-8 | Cardiac Failure
on Sep 07, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Gleevec (View Usage). Patient had the following side effects: cardiac failure. Gleevec dosage: Unk.

6979092-1 | Asthenia, Pleural Effusion, Ulcer, Vomiting
Patient was taking Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: asthenia, pleural effusion, ulcer (What is ulcer?), vomiting on Aug 31, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 61 years of age, was diagnosed with gastrointestinal stromal tumour and. Gleevec dosage: 400 Mg, Unk. Patient was hospitalized.

6975976-9 | Abdominal Pain, Abdominal Pain Lower, Abscess, Ascites, Colonic Fistula, Disseminated Intravascular Coagulation, Hepatic Cirrhosis, Hepatic Function Abnormal, Inflammation
Adverse event was reported on Sep 07, 2010 by a Female patient taking Gleevec (View Usage) (Dosage: 300 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: JAPAN , 81 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal pain lower, abscess (What is abscess?), ascites, colonic fistula, disseminated intravascular coagulation, hepatic cirrhosis, hepatic function abnormal, inflammation. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6974317-0 | Apnoea
on Aug 27, 2010 Female patient from FRANCE , 56 years of age, was treated with Gleevec (View Usage). Patient had the following side effects: apnoea. Gleevec dosage: 400 Mg, Unk. During the same period patient was treated with TASIGNA (400 Mg, Unk) (View Tasigna Review and Tasigna Label ), SPRYCEL (50 Mg, Unk) (View Sprycel Review and Sprycel Label ).

6972865-0 | Abdominal Pain Lower, Abscess, Ascites, Colonic Fistula, Disseminated Intravascular Coagulation, Gastrointestinal Perforation, Haemorrhage, Hepatic Function Abnormal, Large Intestine Perforation
on Sep 07, 2010 Female patient from JAPAN , 81 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: abdominal pain lower, abscess (What is abscess?), ascites, colonic fistula, disseminated intravascular coagulation, gastrointestinal perforation, haemorrhage, hepatic function abnormal, large intestine perforation. Gleevec dosage: Unk. Patient was hospitalized.

6972440-8 | Muscle Spasms, Neutropenia, Pain, Premature Ejaculation, Respiratory Tract Infection, Sinusitis
Patient was taking Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms, neutropenia, pain (What is pain?), premature ejaculation, respiratory tract infection, sinusitis (What is sinusitis?) on Aug 26, 2010 from BRAZIL Additional patient health information: Male patient , 36 years of age, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: 600 Mg Daily. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6970608-8 | Cachexia, Decreased Appetite, Diarrhoea, Gastrointestinal Pain
Adverse event was reported on Aug 27, 2010 by a Female patient taking Gleevec (View Usage) (Dosage: 400 Mg Per Day) was diagnosed with gastrointestinal stromal tumour and. Location: CZECH REPUBLIC , 74 years of age, Patient had the following side effects: cachexia, decreased appetite, diarrhoea, gastrointestinal pain. During the same period patient was treated with LEXAURIN (View Lexaurin Review and Lexaurin Label ), ENDIARON (View Endiaron Review and Endiaron Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

6970597-6 | Conjunctival Hyperaemia, Enanthema, Erythema, Eye Discharge, Pruritus, Pyrexia, Skin Lesion
on Aug 25, 2010 Male patient from JAPAN , 72 years of age, weighting 116.8 lb, was diagnosed with gastrointestinal stromal tumour, abdominal pain upper, eye discharge, conjunctival hyperaemia and was treated with Gleevec (View Usage). After Gleevec was administered, patient had the following side effects: conjunctival hyperaemia, enanthema, erythema, eye discharge, pruritus, pyrexia, skin lesion. Gleevec dosage: 400 Mg, Qd. During the same period patient was treated with PARIET (10 Mg, Daily) (View Pariet Review and Pariet Label ), GLYSENNID (Unk) (View Glysennid Review and Glysennid Label ), MAGMITT (Unk) (View Magmitt Review and Magmitt Label ), FLUMETHOLON (Unk) (View Flumetholon Review and Flumetholon Label ), SOL MELCORT (500 Mg, Unk) (View Sol-melcort Review and Sol-melcort Label ), RINDERON (Unk) (View Rinderon Review and Rinderon Label ), PREDNISOLONE (5 Mg, 8 Tablets Daily) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6970596-4 | Dermatitis Contact, Transplant
on Aug 26, 2010 Male patient from BRAZIL , 36 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Gleevec (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis contact, transplant. Gleevec dosage: 600 Mg.

6968789-5 | Abortion Induced
Patient was taking Gleevec (View Usage). Patient had the following side effects: abortion induced on Aug 25, 2010 from MALAYSIA Additional patient health information: Female patient , weighting 108.0 lb, was diagnosed with chronic myeloid leukaemia and. Gleevec dosage: 400 Mg, Daily. During the same period patient was treated with HYDROXYUREA (500 Mg, Daily) (View Hydroxyurea Review and Hydroxyurea Label ).